Tenax Therapeutics (TENX) Enterprise Value (2010 - 2026)
Tenax Therapeutics recorded quarterly Enterprise Value of -$118.8 million in Q1 2026, down 21.72% quarter-over-quarter from -$97.6 million in Q4 2025, and down 6.56% year-over-year from -$127.1 million in Q1 2025.
Tenax Therapeutics' Enterprise Value history runs 17 years deep, the most recent figure standing at -$118.8 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 6.56% year-over-year to -$118.8 million; the TTM figure through Mar 2026 stood at -$118.8 million (down 6.56% YoY), while the FY2025 annual figure was -$97.6 million, down 2.86% from the prior year.
- Enterprise Value came in at -$118.8 million for Q1 2026 at Tenax Therapeutics, down from -$97.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2.1 million in Q4 2022 to a low of -$118.8 million in Q1 2026.
- A 5-year average of -$47.8 million and a median of -$13.4 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value soared 61.96% in 2022 and plunged 1023.85% in 2025, its largest moves.
- Tenax Therapeutics' Enterprise Value stood at -$2.1 million in 2022, then tumbled by 361.02% to -$9.8 million in 2023, then tumbled by 868.66% to -$94.9 million in 2024, then declined by 2.86% to -$97.6 million in 2025, then decreased by 21.72% to -$118.8 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$118.8 million, -$97.6 million, and -$99.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | -118.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -118.76 Mn |
| Dec 31, 2025 | -97.57 Mn |
| Sep 30, 2025 | -99.37 Mn |
| Jun 30, 2025 | -105.46 Mn |
| Mar 31, 2025 | -111.45 Mn |
| Dec 31, 2024 | -94.85 Mn |
| Sep 30, 2024 | -98.31 Mn |
| Jun 30, 2024 | -9.38 Mn |
| Mar 31, 2024 | -12.55 Mn |
| Dec 31, 2023 | -9.79 Mn |
| Sep 30, 2023 | -11.14 Mn |
| Jun 30, 2023 | -13.39 Mn |
| Mar 31, 2023 | -14.41 Mn |
| Dec 31, 2022 | -2.12 Mn |
| Sep 30, 2022 | -3.81 Mn |
| Jun 30, 2022 | -7.23 Mn |
| Mar 31, 2022 | -2.90 Mn |
| Dec 31, 2021 | -5.58 Mn |
| Sep 30, 2021 | -8.35 Mn |
| Jun 30, 2021 | -2.18 Mn |
| Mar 31, 2021 | -4.03 Mn |
| Dec 31, 2020 | -6.71 Mn |
| Sep 30, 2020 | -8.71 Mn |
| Jun 30, 2020 | -4.55 Mn |
| Mar 31, 2020 | -4.86 Mn |
| Dec 31, 2019 | -5.40 Mn |
| Sep 30, 2019 | -7.13 Mn |
| Jun 30, 2019 | -8.91 Mn |
| Mar 31, 2019 | -10.82 Mn |
| Dec 31, 2018 | -12.86 Mn |
| Sep 30, 2018 | -4.86 Mn |
| Jun 30, 2018 | -6.41 Mn |
| Mar 31, 2018 | -6.62 Mn |
| Dec 31, 2017 | -7.73 Mn |
| Sep 30, 2017 | -8.53 Mn |
| Jun 30, 2017 | -8.80 Mn |
| Mar 31, 2017 | -12.52 Mn |
| Dec 31, 2016 | -13.28 Mn |
| Sep 30, 2016 | -7.48 Mn |
| Jun 30, 2016 | -9.95 Mn |
| Mar 31, 2016 | -3.26 Mn |
| Dec 31, 2015 | -20.19 Mn |
| Sep 30, 2015 | -3.12 Mn |
| Jun 30, 2015 | -6.69 Mn |
| Apr 30, 2015 | -7.93 Mn |
| Apr 30, 2014 | -58.32 Mn |
| Apr 30, 2013 | -783,528.00 |
| Jan 31, 2013 | -828,811.00 |
| Oct 31, 2012 | -1.51 Mn |
| Jul 31, 2012 | -2.69 Mn |
| Apr 30, 2012 | -1.88 Mn |
| Jan 31, 2012 | -3.28 Mn |
| Oct 31, 2011 | -2.00 Mn |
| Jul 31, 2011 | -4.00 Mn |
| Apr 30, 2011 | -951,944.00 |
| Jan 31, 2011 | -522,340.00 |
| Oct 31, 2010 | -837,167.00 |
| Jul 31, 2010 | -2.73 Mn |